FDA Inspection
Philip NMI RaskinPhilip NMI Raskin – FDA Inspection, Feb 20, 2018
Record Details
This FDA Inspection record concerns Philip NMI Raskin, with an inspection on February 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 779f9eca-7e9d-4191-b479-a8f527415e82
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1041550
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Philip NMI Raskin
3| Date | Classification | Office | Project area |
|---|---|---|---|
| January 11, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 4, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 23, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Philip NMI Raskin
- FDA Inspection 1226830 - 2024-01-11
- FDA Inspection 1130798 - 2020-09-04
- FDA Inspection 671386 - 2010-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.